NATIONAL INSTITUTES OF HEALTH FOR IMMEDIATE RELEASE Wednesday, April 15, 1998
|
|
Contact: Gail Blatt (301) 496-7243 (301) 402-0252 (TTY) blattg@ms.nidcd.nih.gov |
New Evidence of Bacteria in Otitis Media
A frequent childhood ear infection called otitis media has been found to be
an ideal model for studying the role of certain bacteria in recurrent
infectious diseases, according to a study supported by the National
Institute on Deafness and Other Communication Disorders (NIDCD). The
research, published in the January 28, 1998, issue of the Journal of American
Medical Association, was conducted at the Center for Genomic Sciences,
University of Pittsburgh School of Medicine. This is the first report
detecting a slow dividing, but active or viable bacterial organism in middle
ear fluid thought to be sterile when analyzed using standard bacterial
culture assays.
Until now, it was thought that the fluid in the middle ear was sterile in
chronic cases of otitis media because samples of the fluid taken from this
area did not contain bacteria. Using a molecular biological technique, the
research team, lead by J. Christopher Post, M.D., and Garth D. Ehrlich, Ph.D.,
found evidence of active bacteria in many of the fluids. These investigators
speculate that this may indicate an infection of longer duration that is
undetectable by current testing techniques.
"These findings provide the foundation that will allow us to understand this
elusive infection leading to better treatment strategies," said James F.
Battey, Jr., M.D., Ph.D., Director, NIDCD.
Otitis media (OM) is an infection of the middle ear. Although it affects
primarily infants and young children, it also affects some adults, and costs
an estimated $5 billion a year in lost wages and medical costs. OM usually
begins with a sore throat, cold or other upper respiratory tract infection
that spreads to the middle ear. When OM becomes persistent, fluid may remain
in the normally air-filled middle ear space. Referred to as chronic otitis
media with effusion (OME), this condition can lead to hearing loss and, in
young children, may lead to developmental speech, language and socialization
difficulties. Otitis media is the most frequent reason for children to be
taken to the emergency room or physicians' offices.
The investigators suggest that the results of this study have implications
beyond understanding otitis media or H. influenzae, one of the major bacteria
known to cause otitis media. H. influenzae causes many other upper
respiratory tract diseases, and there now appear to be strains of H.
influenzae which go undetected using standard laboratory culture techniques.
Most importantly, H. influenzae may serve as a model for similar bacteria
that also have a reduced growth rate making them difficult to detect by the
current methods of testing and difficult to treat with available antibiotics.
In addition, slow dividing bacteria are known to infect implantable medical
devices, such as catheters and artificial joints.
The tip-off to the presence of active bacteria consisted of the mRNA, a
part of the genetic material of H. influenzae. "In previous studies we
identified the DNA of H. influenzae in the sterile middle ear fluid using
molecular biological techniques but its presence did not signify active
bacteria," stated Dr. Ehrlich. "The DNA could have been residue from the
previous infection." He further explained that mRNA, which is made from DNA
in the process of producing the proteins necessary for H. influenzae, only
exists for a short time. Its presence indicates that the bacteria DNA was
actively in the process of producing H. influenzae proteins, thus indicating
an active organism.
Dr. Ehrlich stressed that unfortunately, currently available antibiotics
are not designed to attack this type of bacteria, which are slow dividing
organisms. Their use will most likely have no effect on the middle ear fluid
which needs to be absent from the ear for hearing to be restored. It is
likely that a new arsenal of antibiotics, tailored to attack the slower
dividing bacteria, will need to be designed to effectively treat OME.
As the nation's focal point for research in human communication, the NIDCD
conducts and supports biomedical and behavioral research and research
training on normal mechanisms as well as diseases and disorders of hearing,
balance, smell, taste, voice, speech and language that affects 46 million
Americans.
Top
|
|
|